Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma
- First Online:
- Cite this article as:
- Morton, D.L. Clin Exp Metastasis (2012) 29: 699. doi:10.1007/s10585-012-9503-3
- 1.2k Downloads
This short review offers an update on the first and second Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) for patients with melanoma, and briefly traces the development of intraoperative lymphatic mapping and sentinel node biopsy.